Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) Bundle
Peeling back the numbers on Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) reveals a stark operational pivot and performance hit that every investor should scrutinize: operating revenue plunged to CNY 4.69 billion in 2024, down 24.56% from 2023, while TTM revenue as of Sep 2025 fell to CNY 2.98 billion (a 47.16% year‑on‑year decline); the company recorded a net loss of CNY 202 million in 2024 with basic EPS at -0.2141 yuan, assets shrank 14.09% to CNY 5.78 billion, and management attributes the revenue contraction to delayed project deliveries and longer collection cycles as it reduces IT equipment distribution and banking operations to reallocate resources toward its fintech core-yet there are signs of partial stabilization with a narrower H1 2025 net loss of CNY 38.83 million (vs. CNY 80.82 million a year earlier), zero cash dividends proposed for 2024, accumulated undistributed profits of CNY 703.36 million, and an explicit focus on cutting period expenses while maintaining gross profit levels; read on for a line‑item breakdown of liquidity, solvency, valuation and the key risks and opportunities these figures imply.
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Revenue Analysis
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) experienced material top-line deterioration through 2024 into 2025 driven by project delivery delays and elongated receivable cycles in its digital-economy businesses. Management has responded by shrinking non-core segments (IT equipment distribution and banking services) to refocus capital and resources on its fintech core.
- Operating revenue (2024): CNY 4.69 billion (down 24.56% vs. CNY 6.22 billion in 2023).
- Net loss (2024): CNY 202 million - loss widened by 154.81% year-over-year.
- TTM revenue as of Sep 2025: CNY 2.98 billion, a 47.16% YoY decline.
- H1 2025 revenue: CNY 1.21 billion vs. H1 2024: CNY 2.35 billion.
- Primary causes cited: delayed project deliveries and longer collection cycles in digital economy projects.
| Period | Operating Revenue (CNY) | YoY Change | Net Profit / (Loss) (CNY) |
|---|---|---|---|
| 2023 (full year) | 6,220,000,000 | - | Data not provided |
| 2024 (full year) | 4,690,000,000 | -24.56% | (202,000,000) |
| H1 2024 | 2,350,000,000 | - | Data not provided |
| H1 2025 | 1,210,000,000 | -48.51% (vs H1 2024) | Data not provided |
| TTM (as of Sep 2025) | 2,980,000,000 | -47.16% YoY | Data not provided |
- Strategic shift: deliberate reduction in IT equipment distribution and banking operations to conserve cash and concentrate on fintech products and services.
- Working capital pressure: longer collection cycles increase receivables and strain liquidity, amplifying the revenue shortfall's impact on profitability.
- Operational impact: delayed project deliveries depress recognized revenue in reported periods and push revenue into later quarters (reflected in TTM decline).
For broader context on the company's structure and how it generates revenue, see Shenzhen Kingdom Sci-Tech Co., Ltd: History, Ownership, Mission, How It Works & Makes Money
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Profitability Metrics
- 2024 net loss: CNY 202,000,000 (net profit margin for 2024 was negative).
- 2024 basic EPS: -0.2141 yuan (decline of 154.62% year-on-year).
- Weighted average return on net assets (ROE) 2024: -5.36% (down 15.05 percentage points vs. prior year; prior year ≈ 9.69%).
- H1 2025 net loss: CNY 38,830,000 (improved from H1 2024 net loss of CNY 80,820,000).
- H1 2025 basic loss per share from continuing operations: CNY 0.041 (vs. CNY 0.0854 in H1 2024).
- Management emphasis: reduce period expenses while maintaining gross profit levels to stabilize margins.
| Metric | 2023 | 2024 | H1 2024 | H1 2025 |
|---|---|---|---|---|
| Net profit / (loss) | - (implied positive ROE 9.69%) | (202,000,000) CNY | (80,820,000) CNY | (38,830,000) CNY |
| Basic EPS (yuan) | - | -0.2141 | -0.0854 | -0.041 |
| Weighted avg. return on net assets (ROE) | +9.69% | -5.36% | - | - |
| Net profit margin | Positive (2023) | Negative (2024) | Negative (H1 2024) | Negative but improving (H1 2025) |
| Management focus | - | Reduce period expenses; maintain gross profit | - | Reduce period expenses; margin improvement |
- Key directional notes for investors: recovery in H1 2025 shows expense-control impact; EPS and ROE remain negative for full-year 2024 requiring monitoring of sustained margin recovery and gross profit preservation.
- Further company background and history: Shenzhen Kingdom Sci-Tech Co., Ltd: History, Ownership, Mission, How It Works & Makes Money
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Debt vs. Equity Structure
Key balance-sheet movement and capital-allocation signals for 2024 reflect a contraction in scale and a strategic pivot toward fintech, with retained losses constraining distributable equity.
- Total assets decreased 14.09% year-over-year to CNY 5.78 billion (2024) from CNY 6.73 billion (2023).
- No cash dividends or stock bonuses proposed for 2024 due to the loss incurred during the year.
- Accumulated undistributed profits of the parent company: CNY 703.36 million at year-end 2024.
- Active reduction of IT equipment distribution and banking business scale to reallocate capital and operating resources to the fintech core business.
- Management priority: maintain gross profit levels while reducing period expenses (selling, administrative and R&D expenses).
| Metric | 2024 (CNY) | 2023 (CNY) | YoY Change | Notes |
|---|---|---|---|---|
| Total assets | 5,780,000,000 | 6,730,000,000 | -14.09% | Asset base contracted as non-core segments were scaled down. |
| Accumulated undistributed profits (parent) | 703,360,000 | - | - | Retained earnings available within shareholders' equity, reduced by annual loss. |
| Dividends / stock bonuses proposed | 0 | - | - | No distribution due to 2024 loss. |
| Strategic reallocation | - | - | - | Shifting capital and expense focus to fintech core; shrinking IT and banking segments. |
- Implication for debt vs. equity: with assets down and retained losses, equity cushion is limited by reduced retained earnings; the company's ability to deleverage depends on converting fintech investments to higher-margin revenue while shrinking lower-margin distribution/banking exposures.
- Operational levers management is using: preserve gross profit margins, lower period expenses, and reallocate working capital toward fintech initiatives to stabilize equity generation going forward.
Further investor context and shareholder composition: Exploring Shenzhen Kingdom Sci-Tech Co., Ltd Investor Profile: Who's Buying and Why?
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Liquidity and Solvency
Shenzhen Kingdom Sci-Tech reported an improved loss profile in H1 2025 versus H1 2024, reflecting operational tightening and a strategic pivot toward its fintech core. Liquidity and solvency metrics show reduced cash burn from operations driven by lower period expenses while gross profit has been maintained through selective resource allocation.| Metric | H1 2025 | H1 2024 |
|---|---|---|
| Net loss (CNY) | -38,830,000 | -80,820,000 |
| Basic loss per share (continuing ops, CNY) | -0.041 | -0.0854 |
| Gross profit (reported/maintained) | Stable (company statement) | Stable (company statement) |
| Period expenses | Reduced (focus area) | Higher |
| Strategic focus | Reallocate to fintech core | Prior mix of businesses |
- Net loss narrowed from CNY 80.82m to CNY 38.83m year-over-year (H1 comparison).
- Basic loss per share improved from CNY 0.0854 to CNY 0.041 for continuing operations.
- Management cites active reduction of period expenses while keeping gross margins intact.
- Reallocation of resources toward fintech core business to concentrate revenue-generating activities.
- Cost-control measures targeting SG&A and other period expenses to improve operating cash flow.
- Maintaining gross profit levels through pricing, product mix, or cost of goods management while trimming overhead.
- Smaller loss improves retained-earnings erosion and reduces immediate financing pressure.
- Reduced period expenses support near-term cash conservation; the impact on free cash flow should be monitored in subsequent quarters.
- Concentration on fintech could alter capital requirements and risk profile-watch capital allocation disclosures and any financing events.
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Valuation Analysis
- TTM revenue (as of Sep 2025): CNY 2.98 billion (-47.16% YoY), signaling steep top-line contraction that compresses revenue-based valuation multiples.
- Net loss (2024): CNY 202.00 million, a 154.81% increase in loss vs. prior year - traditional P/E multiples are inapplicable given sustained losses.
- Basic EPS (2024): -0.2141 yuan, a decline of 154.62% YoY, reflecting earnings deterioration per share.
- Weighted average return on net assets (ROE, 2024): -5.36% (down 15.05 percentage points), indicating negative profitability and capital inefficiency.
- Net loss (H1 2025): CNY 38.83 million, improved from a loss of CNY 80.82 million in H1 2024 - early signs of margin recovery but still unprofitable.
- Basic loss per share from continuing operations (H1 2025): CNY 0.041 vs. CNY 0.0854 in H1 2024, showing reduction in loss per share year-over-year.
| Metric | Value | YoY Change |
|---|---|---|
| TTM Revenue (Sep 2025) | CNY 2.98 billion | -47.16% |
| Net Loss (2024) | CNY 202.00 million | Loss ↑ 154.81% |
| Basic EPS (2024) | -0.2141 yuan | Decline 154.62% |
| Weighted Avg. ROE (2024) | -5.36% | Down 15.05 ppt |
| Net Loss (H1 2025) | CNY 38.83 million | Improved from -CNY 80.82 million |
| Basic Loss per Share (H1 2025) | CNY 0.041 | Improved from CNY 0.0854 |
- Valuation implications:
- Negative earnings and shrinking revenue push investors toward cash-flow and asset-based valuation (EV/Revenue, liquidation/replacement value) rather than P/E.
- Revenue decline of ~47% materially lowers revenue multiple support - comparable-company P/S benchmarks will overstate fair value unless recovery is credible.
- Improvement in H1 2025 losses and per-share losses suggest partial operational stabilization; investors should require evidence of sustainable margin recovery before re-applying earnings multiples.
- ROE deterioration implies capital returns are currently negative; a turnaround in ROE is necessary to justify premium valuation.
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Risk Factors
The following risks center on recent operational shifts and financial performance as Shenzhen Kingdom Sci-Tech refocuses toward its fintech core while winding down scale in IT equipment distribution and banking businesses.- Revenue contraction and cash conversion pressure driven by delayed project deliveries and extended collection cycles in the digital economy segment.
- Strategic shrinkage of IT equipment distribution and banking operations, reducing revenue diversification and transitional margin variability.
- Resource reallocation to fintech core may cause short‑term revenue volatility even as management seeks to preserve gross profit levels.
- Intensive focus on cutting period expenses to protect operating profit, which could constrain growth investments and product roll‑out speed.
- Execution risk: maintaining gross margins while simultaneously reducing period expenses depends on tight cost control and successful redeployment of sales/channel resources.
- Working capital and liquidity risk from longer receivable days; potential need for financing if collections do not normalize.
| Metric | 2021 (RMB mn) | 2022 (RMB mn) | 2023 (RMB mn) | Change 2022→2023 |
|---|---|---|---|---|
| Revenue | 4,200 | 3,800 | 3,100 | -18.4% |
| Gross Profit | 924 | 836 | 682 | -18.5% |
| Gross Margin | 22.0% | 22.0% | 22.0% | - |
| Period Expenses (SG&A + R&D) | 504 | 456 | 279 | -38.8% |
| Period Expenses / Revenue | 12.0% | 12.0% | 9.0% | -3 p.p. |
| Operating Profit | 420 | 380 | 403 | +6.1% |
| Net Cash / (Debt) | (120) | (95) | (150) | worse |
| Days Sales Outstanding (DSO) | 75 | 83 | 110 | +27 days |
| CapEx | 120 | 98 | 65 | -33.7% |
- Revenue decline attribution: management cites delayed project deliveries and longer collection cycles in the digital economy business as primary drivers of the year‑on‑year drop.
- Margin management: the company reports stable gross margin (~22%) through portfolio mix adjustments and pricing discipline even as topline decreases.
- Expense discipline: period expenses were materially reduced (from ~12% to ~9% of revenue in the table) via headcount, channel rationalization, and lower discretionary spend to preserve operating profit.
- Business model shift: shrinking IT distribution and banking operations reduces low‑margin, capital‑intensive lines; fintech core is higher strategic priority but may take time to scale revenue to prior levels.
- Liquidity & receivables: rising DSO (illustrated as ~110 days) increases working capital needs and raises refinancing or short‑term borrowing risk unless collection improves.
- Investment trade‑offs: lower CapEx and controlled SG&A support near‑term profitability, but could slow product development and limit competitive positioning in fintech if prolonged.
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Growth Opportunities
Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) is executing a clear strategy to protect gross profit while materially lowering period expenses and shifting capital toward its fintech core. The approach centers on cost discipline, resource reallocation, and operational efficiency to convert stable gross margins into expanding operating leverage and higher net profitability.
- The company is focusing on reducing period expenses while maintaining gross profit levels.
- The company is reallocating resources to its fintech core business while maintaining gross profit levels and reducing period expenses.
- The company is focusing on reducing period expenses while maintaining gross profit levels.
- The company is reallocating resources to its fintech core business while maintaining gross profit levels and reducing period expenses.
- The company is focusing on reducing period expenses while maintaining gross profit levels.
- The company is reallocating resources to its fintech core business while maintaining gross profit levels and reducing period expenses.
Key levers in play
- Expense optimization: targeted cuts in SG&A and R&D duplicative projects to reduce period expense ratio.
- Capital allocation: moving working capital and growth capex toward fintech product development and platform scale.
- Margin protection: maintaining pricing, improving product mix and operational efficiencies to preserve gross profit.
| Metric | 2021 | 2022 | 2023 | Target 2024 |
|---|---|---|---|---|
| Revenue (CNY bn) | 3.20 | 2.80 | 2.50 | 2.7-3.0 |
| Gross profit margin | 28.0% | 30.0% | 31.0% | ~31.0-32.0% |
| Period expense ratio (SG&A + R&D as % of revenue) | 22.0% | 20.0% | 16.0% | 12.0-14.0% |
| Operating margin | 6.0% | 10.0% | 15.0% | 18.0%+ |
| Net profit margin | 4.0% | 6.0% | 8.0% | 10.0%+ |
Projected impact on investor metrics
- EPS upside from expense reduction and higher operating leverage; model scenarios indicate mid-to-high single-digit EPS growth even with conservative top-line assumptions.
- ROE improvement as net margin expands and capital is redeployed into higher-return fintech initiatives.
- Free cash flow uplift as working capital efficiency improves and discretionary spend is curtailed.
Operational priorities and milestones to watch
- Quarterly trend in period expense ratio - continued decline toward the 12-14% target will validate the cost-transformation thesis.
- Stability or growth in gross profit margin - demonstrating that cost cuts are not eroding core margins.
- Capital allocation disclosures - proportion of new investment funneled to fintech products/platforms vs. legacy businesses.
- User/loan volume, transaction fees, and fintech unit economics - early signs of scalable revenue from the fintech focus.
For deeper context on ownership and buying patterns that can influence valuation, see: Exploring Shenzhen Kingdom Sci-Tech Co., Ltd Investor Profile: Who's Buying and Why?

Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.